{'Year': '2016'}
Pharmacogenomically actionable medications in a safety net health care system.
Prior to implementing a trial to evaluate the economic costs and clinical outcomes of pharmacogenetic testing in a large safety net health care system, we determined the number of patients taking targeted medications and their clinical care encounter sites.